WATCH NOW
Solid Biosciences Webinar | September 2025
On September 10, 2025, Solid Biosciences’ Matthew Harmelink, MD, Therapeutic Area Head of Neuromuscular, and Seth Rotberg, Senior Manager of Patient Advocacy, joined FARA to provide an overview of the upcoming FALCON gene therapy study (SGT-212) and take questions directly from the FA community.
